News

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer
AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...
BioPharma Dive2d
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...
AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1)
An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...
Keeping AstraZeneca's Edge in Oncology: Vanguards of Health Care
Understand every aspect of the global economy – and know how to make your next move.
KSL9d
AstraZeneca sues Utah attorney general over new Utah drug price law
The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on ...
AstraZeneca: Fascinating Company With Lofty Ambitions - Just Not A Buy Yet
AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.
Explore more
AstraZeneca sues Utah attorney general over new drug pricing law
AstraZeneca, a major pharmaceutical company, has sued Utah’s Attorney General Derek Brown over a recently passed state law ...
VOV.VN2d
AstraZeneca encouraged to build pharmaceutical manufacturing plant in Vietnam
VOV.VN - Prime Minister Pham Minh Chinh has proposed that AstraZeneca consider building a pharmaceutical manufacturing plant ...